A Clinical Trial of Iron Supplementation for Youth With ADHD and Restless Sleep
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Study ID
- NCT07061470
- Phase
- PHASE1/PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- ADHD
- Sleep Problems
Eligibility Criteria
- Sex
- ALL
- Age
- 8 Years - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Ferrous Sulfate — DIETARY_SUPPLEMENTDosing of the iron supplement will be based on weight.
- Placebo — OTHERPlacebo pills will be provided to participants in the placebo arm
Study Details
The goal of this clinical trial is to learn if iron supplementation works to restless sleep in youth with ADHD. A second goal is to learn if iron supplementation helps to ease ADHD symptoms. The main questions that this trial aims to answer are: Does 3 months of iron supplementation treatment improve parent- and youth self-reported sleep difficulties more than placebo? Does 3 months of iron supplementation treatment improve sleep as measured by actigraphy more than placebo? Does 3 months of iron supplementation treatment improve parent-reported and/or objectively measured attention more than placebo? Researchers will compare over-the-counter iron supplementation treatment to a placebo (a look-alike substance that contains no drug) to see if iron supplementation works to treat sleep difficulties in youth with ADHD. Participants will: * Take iron supplements every day for 3 months * Visit the clinic once before treatment begins and once at the end of treatment to complete tests and rating scales related to sleep and attention * Wear motion-monitoring leg bands while sleeping for one 2-week period before treatment begins and one 2-week period at the end of treatment
Key Dates
- Start date
- Mar 1, 2027
- Status verified
- Apr 2026
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Iron supplementation armParticipants in the iron supplementation arm will receive 3 months of iron supplementation treatment
- Placebo Comparator: Placebo armParticipants in the placebo arm will receive 3 months of placebo treatment
Primary Outcome Measure
Sleep Efficiency [ Time Frame: Sleep efficiency will be assessed nightly for 2 weeks before treatment begins and then again for 2 weeks at the end of treatment. ]
Central Contacts
- Alison E Pritchard, PhD443-904-2488
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Kennedy Krieger Institute | Baltimore | Maryland | 21231 |
Find similar trials in Baltimore, MD
Related Studies
- Role of Theta Frequency Oscillations in Proactive and Reactive Control Processes in Youth With Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive Compulsive Disorder (OCD)Not Yet Recruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland
- Virtual Reality Attention ManagementRecruiting · University of California, Davis · Sacramento, California
- Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHDPHASE4 · Recruiting · Icahn School of Medicine at Mount Sinai · Gainesville, Florida
- Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD RiskPHASE4 · Recruiting · Icahn School of Medicine at Mount Sinai · New York, New York